These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
634 related items for PubMed ID: 18096277
1. Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis. Khan AA, Babu JP, Gupta G, Rao DN. Vaccine; 2008 Jan 17; 26(3):316-32. PubMed ID: 18096277 [Abstract] [Full Text] [Related]
2. Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice. Uppada SB, Bhat AA, Sah A, Donthamshetty RN. Vaccine; 2011 Nov 21; 29(50):9352-60. PubMed ID: 22001881 [Abstract] [Full Text] [Related]
10. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model. Ali R, Naqvi RA, Kumar S, Bhat AA, Rao DN. Scand J Immunol; 2013 May 21; 77(5):361-71. PubMed ID: 23480362 [Abstract] [Full Text] [Related]
11. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target. Manocha M, Pal PC, Chitralekha KT, Thomas BE, Tripathi V, Gupta SD, Paranjape R, Kulkarni S, Rao DN. Vaccine; 2005 Dec 01; 23(48-49):5599-617. PubMed ID: 16099080 [Abstract] [Full Text] [Related]
12. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis. Kaur M, Chug H, Singh H, Chandra S, Mishra M, Sharma M, Bhatnagar R. Mol Immunol; 2009 Jun 01; 46(10):2107-15. PubMed ID: 19356802 [Abstract] [Full Text] [Related]
13. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles. Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN. FEMS Immunol Med Microbiol; 2003 Oct 15; 38(3):215-29. PubMed ID: 14522457 [Abstract] [Full Text] [Related]
14. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity. Eyles JE, Butcher WA, Titball RW, Hill J. Vaccine; 2007 Oct 16; 25(42):7301-6. PubMed ID: 17869388 [Abstract] [Full Text] [Related]
17. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague. Zauberman A, Cohen S, Levy Y, Halperin G, Lazar S, Velan B, Shafferman A, Flashner Y, Mamroud E. Vaccine; 2008 Mar 20; 26(13):1616-25. PubMed ID: 18304706 [Abstract] [Full Text] [Related]
18. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains. Sabhnani L, Manocha M, Tomar D, Shashikiran D, Rao DN. Int Immunopharmacol; 2003 Oct 20; 3(10-11):1413-8. PubMed ID: 12946437 [Abstract] [Full Text] [Related]